How to Buy Treace Medical Concepts Stock
Treace Medical Concepts Inc
Treace Medical Concepts, Inc. , an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States.
Treace Medical Concepts stock last closed at $6.44, down 0.16% from the previous day, and has decreased 41.98% in one year. It has underperformed other stocks in the Medical Devices industry by 0.23 percentage points. Treace Medical Concepts stock is currently +64.29% from its 52-week low of $3.92, and -43.46% from its 52-week high of $11.39.
At the moment, there are 62.62M shares of TMCI outstanding. The market capitalization of TMCI is $403.26M. In the past 24 hours, 408,938 TMCI shares were traded.
How to Buy Treace Medical Concepts Stock
Wondering how to invest in Treace Medical Concepts stock? Here's how.
- Decide where to buy Treace Medical Concepts stock: You need to decide on a stock brokerage, but don't worry - we've researched dozens of online brokerages and apps to help you decide where to buy Treace Medical Concepts stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your investment account: Pick your method of payment and add your information.
- Research Treace Medical Concepts stock: The Treace Medical Concepts ticker symbol is TMCI. Is Treace Medical Concepts stock a good investment? Should you buy shares of TMCI? How do TMCI's underlying business fundamentals look? Do top analysts think Treace Medical Concepts is a good buy? Why has TMCI's stock price moved recently? (Hint: Our stock research website can help you evaluate if TMCI is a good stock to buy).
- Execute your TMCI buy order: Decide if you will purchase TMCI shares at the current market price or use a limit order to buy TMCI stock at a given price.
- Get the latest scoop on your investment in TMCI: Create a watchlist to watch your position in Treace Medical Concepts stock.
Step 1: Decide where to buy Treace Medical Concepts stock
You will need a brokerage account to access the NASDAQ market and buy TMCI shares.
Our recommended brokerage: eToro
Based on our research, eToro is the best online stock brokerage. Here's why:
- You can invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
- Access to global financial markets: From Technology to Utilities, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro offers a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by signing up for an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal details so you are able to buy TMCI today.
How to Set Up a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to create a new trading account.
- Submit your data by hitting the "Create Account" button. Get started with eToro today
Step 3: Put funds into your investment account
Now that you have created your account on a investment app, you can securely and quickly fund your account:
Watch the walkthrough below for more details depositing money into your new investment account.
Step 4: Research Treace Medical Concepts stock
Once you have selected the best place to buy Treace Medical Concepts stock, it's important to research their stock prior to investing, so you truly wrap your head around the risk and upside.
Treace Medical Concepts Numbers
Fundamentals of Treace Medical Concepts
WallStreetZen was created to help everyday investors do more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on TMCI's stock page.
Is TMCI stock overvalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge TMCI's true value.
Using relative valuations ratios:
- TMCI may be undervalued based on its P/B ratio of 3.57x, relative to Medical Devices industry P/B ratio of 3.74x
You can access more valuation research on TMCI's stock here.
TMCI Financial Health Overview
Pros:
- TMCI has cash burn of 48760000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than long-term liabilities on the TMCI balance sheet.
- There are more short-term assets than short-term liabilities on the TMCI balance sheet.
- Total TMCI debt is lower than 5 years ago, relative to shareholder equity.
Cons:
- TMCI has $75.68M in cash and short term investments. This is not enough to cover its annual cash burn of $48.76M.
- TMCI profit margin has gone down from -26.5% to -26.6% in the past year.
- TMCI has a relatively high debt to equity ratio of 0.92.
Do analysts think it's a good time to buy TMCI stock
Out of 4 Wall Street analysts who monitor TMCI, the consensus analyst rating on Treace Medical Concepts is a Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
You can dig deeper into what analysts are projecting on the Treace Medical Concepts stock forecast page.
TMCI Technical Indicators
TMCI Revenue
Last year, TMCI revenue was $209.36M. Over the last 5 year, TMCI's revenue has grown by 39.65% per year. This was faster than the Medical Devices industry average of 9.8%.
Find out more about TMCI's earnings and revenue performance here.
Are TMCI executives and large shareholders buying or selling the stock?
In the last year, executives and large shareholders at TMCI have bought more shares than they have sold.
Sean F. Scanlan, Chief Innovation Officer of TMCI, was the latest TMCI insider to buy. They bought $52,500.00 worth of TMCI stock on Mar 17, 2025.
Dig into more about who owns TMCI shares here.
Can I rely on TMCI as an income stream?
No, Treace Medical Concepts doesn't provide an income stream by paying out dividends.
TMCI Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your TMCI buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are generally fine. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a particular price, place a limit order.
Hit the Open Trade button and eToro will execute the order.
If you want more help investing in stocks on eToro, click the how to video below:
Step 6: Get the latest scoop on your investment in TMCI
Now that you own some shares in TMCI, you'll want to keep up with your new investment.
Make a watchlist to monitor your TMCI stock.
TMCI Feed
How to Buy Stock in Treace Medical Concepts
To summarize, here are the 6 steps to buy stock in Treace Medical Concepts:
- Decide where to buy Treace Medical Concepts stock
- Sign up for a brokerage account
- Put funds into your investment account
- Research Treace Medical Concepts stock
- Execute your TMCI buy order
- Get the latest scoop on your investment in TMCI
If you need a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you want to get updates on your investment in Treace Medical Concepts, create a watchlist today.
Trending Content
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.